Literature DB >> 1537389

Interleukin 6-induced differentiation of a human B cell line into IgM-secreting plasma cells is mediated by c-fos.

D Körholz1, S Gerdau, J Enczmann, N Zessack, S Burdach.   

Abstract

The role of the protooncogene c-fos in interleukin (IL) 6-induced B cell differentiation was assessed. Treatment of SKW 6.4 cells with IL 6 induced a transient and early stimulation of c-fos sense mRNA expression. The effect appeared within 30 min and returned to basal levels after 2 h. The addition of antisense oligonucleotides to c-fos significantly inhibited IL 6-induced IgM production by SKW 6.4 cells (p less than 0.001), whereas control oligonucleotides had no inhibitory effect. These results indicate that activation of c-fos is involved in IL 6-induced differentiation of SKW 6.4 cells into IgM-secreting cells.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1537389     DOI: 10.1002/eji.1830220248

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  4 in total

1.  Interferon-gamma induces the expression of immediate early genes c-fos and c-jun in astrocytes.

Authors:  N Rubio
Journal:  Immunology       Date:  1997-08       Impact factor: 7.397

2.  Brequinar sodium inhibits interleukin-6-induced differentiation of a human B-cell line into IgM-secreting plasma cells.

Authors:  K Tamura; J Woo; M T Bakri; A W Thomson
Journal:  Immunology       Date:  1993-08       Impact factor: 7.397

3.  Antagonism of cannabinoid receptor 2 pathway suppresses IL-6-induced immunoglobulin IgM secretion.

Authors:  Rentian Feng; Christine A Milcarek; Xiang-Qun Xie
Journal:  BMC Pharmacol Toxicol       Date:  2014-06-09       Impact factor: 2.483

4.  The AP-1 transcription factor Fra1 inhibits follicular B cell differentiation into plasma cells.

Authors:  Bettina Grötsch; Sebastian Brachs; Christiane Lang; Julia Luther; Anja Derer; Ursula Schlötzer-Schrehardt; Aline Bozec; Simon Fillatreau; Ingolf Berberich; Elias Hobeika; Michael Reth; Erwin F Wagner; Georg Schett; Dirk Mielenz; Jean-Pierre David
Journal:  J Exp Med       Date:  2014-10-06       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.